Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 216

1.

Venom therapy in multiple sclerosis.

Mirshafiey A.

Neuropharmacology. 2007 Sep;53(3):353-61. Review.

PMID:
17583756
2.

Complementary and alternative medicine: is there a role in multiple sclerosis?

Yadav V, Bourdette D.

Curr Neurol Neurosci Rep. 2006 May;6(3):259-67. Review.

PMID:
16635436
3.

A review of complementary and alternative medicine (CAM) by people with multiple sclerosis.

Olsen SA.

Occup Ther Int. 2009;16(1):57-70. doi: 10.1002/oti.266. Review.

PMID:
19222053
4.

Therapeutic potential of venom peptides.

Lewis RJ, Garcia ML.

Nat Rev Drug Discov. 2003 Oct;2(10):790-802. Review.

PMID:
14526382
5.

Prevention of experimental allergic encephalomyelitis with cobra venom factor.

Abrahamson HA.

J Asthma Res. 1971 Jun;8(4):151-2. No abstract available.

PMID:
5119401
6.

Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.

Pula JH, Javed A.

Curr Opin Ophthalmol. 2009 Nov;20(6):476-81. doi: 10.1097/ICU.0b013e3283319155. Review.

PMID:
19816177
7.

Targeting PPAR as a therapy to treat multiple sclerosis.

Bright JJ, Walline CC, Kanakasabai S, Chakraborty S.

Expert Opin Ther Targets. 2008 Dec;12(12):1565-75. doi: 10.1517/14728220802515400 . Review.

PMID:
19007323
8.

Current Complementary and Alternative Therapies for Multiple Sclerosis.

Bowling AC, Stewart TM.

Curr Treat Options Neurol. 2003 Jan;5(1):55-68.

PMID:
12521563
9.

Antioxidant therapy in multiple sclerosis.

Mirshafiey A, Mohsenzadegan M.

Immunopharmacol Immunotoxicol. 2009;31(1):13-29. doi: 10.1080/08923970802331943. Review.

PMID:
18763202
10.

Complementary therapy use by persons with multiple sclerosis: benefits and research priorities.

Esmonde L, Long AF.

Complement Ther Clin Pract. 2008 Aug;14(3):176-84. doi: 10.1016/j.ctcp.2008.03.001.

PMID:
18640629
12.

Anticancer potential of animal venoms and toxins.

Gomes A, Bhattacharjee P, Mishra R, Biswas AK, Dasgupta SC, Giri B.

Indian J Exp Biol. 2010 Feb;48(2):93-103. Review.

PMID:
20455317
13.

Modern multiple sclerosis treatment - what is approved, what is on the horizon.

Pilz G, Wipfler P, Ladurner G, Kraus J.

Drug Discov Today. 2008 Dec;13(23-24):1013-25. doi: 10.1016/j.drudis.2008.08.003. Review.

PMID:
18775508
14.

Complementary and alternative medicines and dietary interventions in multiple sclerosis: what is being used in South Australia and why?

Leong EM, Semple SJ, Angley M, Siebert W, Petkov J, McKinnon RA.

Complement Ther Med. 2009 Aug;17(4):216-23. doi: 10.1016/j.ctim.2009.03.001.

PMID:
19632549
15.
16.

Use of venom peptides to probe ion channel structure and function.

Dutertre S, Lewis RJ.

J Biol Chem. 2010 Apr 30;285(18):13315-20. doi: 10.1074/jbc.R109.076596. Review.

17.

Venom as a source of useful biologically active molecules.

Bailey P, Wilce J.

Emerg Med (Fremantle). 2001 Mar;13(1):28-36. Review.

PMID:
11476408
18.

Towards immunotherapeutic drugs and vaccines against multiple sclerosis.

Katsara M, Matsoukas J, Deraos G, Apostolopoulos V.

Acta Biochim Biophys Sin (Shanghai). 2008 Jul;40(7):636-42. Review.

19.

Pharmacological treatment of pain in multiple sclerosis.

Solaro C, Tanganelli P, Messmer Uccelli M.

Expert Rev Neurother. 2007 Sep;7(9):1165-74. Review.

PMID:
17868015
20.

Venom evolution through gene duplications.

Wong ES, Belov K.

Gene. 2012 Mar 15;496(1):1-7. doi: 10.1016/j.gene.2012.01.009. Review.

PMID:
22285376
Items per page

Supplemental Content

Support Center